Myopathies

Myopathies are genetic or acquired disorders of skeletal muscle that lead to varying degrees of weakness, atrophy, and exercise intolerance. Here are the latest discoveries pertaining to this disease.

August 1, 2020
Preprint

Specific mutations in genes responsible for Alzheimer and for Duchenne Muscular Dystrophy introduced by Base editing and PRIME editing.

BioRxiv : the Preprint Server for Biology
J. RousseauJacques P Tremblay
July 29, 2020
Open Access

Effect of serotonin modulation on dystrophin-deficient zebrafish

Biology Open
Janelle M SpinazzolaLouis M Kunkel
July 25, 2020
Review

Limb Girdle Muscular Dystrophies

Neurologic Clinics
Jacob Bockhorst, Matthew Wicklund
July 29, 2020
Open Access

Use of Castor Bean Meal, Biodiesel Industry Coproduct, in A Lamb Production System Using Creep-Feeding in Brazil

Animals : an Open Access Journal From MDPI
Marco A S NovaesGleidson G P Carvalho
August 4, 2020

What Is Anaphylaxis? Pediatric Residents' Perception and Treatment of Anaphylactic Reactions

Clinical Pediatrics
Ronald M Ferdman
July 30, 2020

Epilepsy in patients with advanced Fukuyama congenital muscular dystrophy

Brain & Development
Ryoko KuwayamaKeiko Yanagihara
July 30, 2020
Review

Hyperekplexia and other startle syndromes

Journal of the Neurological Sciences
Arushi Gahlot Saini, Sanjay Pandey
August 3, 2020

Obstructive sleep apnea syndrome and autonomic dysfunction in Duchenne muscular dystrophy

Sleep & Breathing = Schlaf & Atmung
Gulcin Benbir SenelDerya Karadeniz
July 29, 2020
Open Access

Regulation of myonuclear positioning and muscle function by the skeletal muscle-specific CIP protein

Proceedings of the National Academy of Sciences of the United States of America
Jianming LiuDa-Zhi Wang
July 27, 2020
Preprint
Open Access

Molecular mechanisms of Cardiac Injury associated with myocardial SARS-CoV-2 infection

BioRxiv : the Preprint Server for Biology
X. LiuLei Zhou
July 31, 2020

Golodirsen (Vyondys 53) for Duchenne muscular dystrophy

The Medical Letter on Drugs and Therapeutics
July 28, 2020
Open Access

Aging-Dependent Genetic Effects Associated to ADHD Predict Longitudinal Changes of Ventricular Volumes in Adulthood

Frontiers in Psychiatry
Natalia Vilor-TejedorHieab H H Adams
August 1, 2020
Open Access

Dichotic Perception of Lexical Tones in Cantonese-Speaking Congenital Amusics

Frontiers in Psychology
Jing Shao, Caicai Zhang
July 28, 2020
Open Access

Short-Term ONX-0914 Administration: Performance and Muscle Phenotype in Mdx Mice

International Journal of Environmental Research and Public Health
Dongmin KwakJong-Hee Kim
August 2, 2020
Case Report

Is heart transplantation a real option in patients with Duchenne syndrome? Inferences from a case report

ESC Heart Failure
Antonio PiperataGino Gerosa
July 24, 2020
Correction

Correction: Expression profiling of disease progression in canine model of Duchenne muscular dystrophy

PloS One
Candice Brinkmeyer-LangfordJoe N Kornegay
July 20, 2020

Phenotypic and genotypic analysis of limb-Girdle muscular dystrophy type 2B

Neurosciences : the Official Journal of the Pan Arab Union of Neurological Sciences
Khalid H AldosariHisham M Alkhalidi

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2020 Meta ULC. All rights reserved
/feed-previews/myopathies/9de930b7-b10d-4f2c-9057-57af8e13ec88